Skip to main content

Binita Shah, MD

  • Specialty: Interventional Cardiology
  • Languages: English, Hindi, Spanish
  • Phone: 212-263-5656
View Locations
More Than 1,800 Coronary Catheter Procedures
Associate Director of Research for the Cardiac Catheterization Laboratory
More Than 40 Peer-Reviewed Medical Journal Publications

About Me

At NYU Langone’s Cardiac Catheterization Laboratory, I provide treatment for people whose arteries are blocked due to heart disease. Every person’s diagnosis is different, so care starts with a series of questions. What is the extent of the blockage? Does the artery need to be opened with a stent, or can it be treated with medication? If a procedure is needed, what is the best approach? It’s this challenge—to solve unique problems with creative solutions—that led me to become an interventional cardiologist.

For each patient, my team looks at numerous factors before coming up with a treatment plan. We consider a person’s age, overall health, the extent of the blockage, and its location. We then determine the best technique for opening the artery. Most often this involves the use of stents, which help restore healthy blood flow. Sometimes a person has more than one blockage, and that factors into our planning as well.

I specialize in radial artery catheterization, a technique in which we access the coronary arteries by placing a catheter in an artery in the wrist. Another option is to use an artery in the groin, but research shows that for most patients, radial access is better. This is especially true for people who need complicated procedures or have other health issues.

When possible, I encourage my patients to ask questions before we start a procedure. I do my best to explain the recommended treatment and associated risks, and I encourage shared decision-making. It’s important that I understand my patients concerns so I can help them return to their active lives.

During my medical training, I realized that I excel in emergency situations. I can steer the ship and stay calm, which is important in interventional cardiology. It’s immensely satisfying to know that because of my care, people walk out of the hospital and can be with their families. That is the part of the job that makes it all worthwhile.

Conditions and Treatments

  • heart attack
  • inflammation of the heart valve
  • aortic valve insufficiency
  • peripheral vascular disease
  • claudication
  • congestive heart failure
  • critical limb ischemia
  • arterial occlusive disease
  • mitral regurgitation
  • critical limb ischemia
  • acute coronary syndrome
  • chest pain
  • carotid artery disease
  • mitral valve stenosis
  • heart muscle disease
  • high blood pressure disorder
  • aortic valve disease
  • coronary heart disease
  • carotid stenosis
  • renal artery stenosis
  • antiplatelet therapy
  • cardiac catheterization


  • Assistant Professor, Department of Medicine
  • Director, Internal Medicine Residency Research
Board Certifications
  • American Board of Internal Medicine (Interventional Cardiology), 2012
  • American Board of Internal Medicine (Cardiovascular Disease), 2010
Education and Training
  • Fellowship, NYU School of Medicine, Interventional Cardiology, 2012
  • Fellowship, NYU Medical Center, Interventional Cardiology, 2011
  • Fellowship, NYU Medical Center, Medicine/Cardiology, 2010
  • Residency, NYU Medical Center, Internal Medicine, 2007
  • MD from New York University, 2004

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Agewell
    • Agewell
  • Amidacare
    • Amidacare
  • Centerlight
    • Centerlight
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • ElderPlan
    • ElderPlan
  • Emblem
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Family Health
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
    • GHI CBP
    • GHI HMO
  • HIP
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP Essential
    • HIP Family Health
    • HIP HMO
    • HIP Medicaid
    • HIP Medicare
    • HIP POS
  • HealthSmart
    • HealthSmart (WTC)
  • Healthfirst
    • Healthfirst
    • Healthfirst Essential
  • Hotel Trades
    • Hotel Trades
  • Humana
    • Humana Medicare
  • Local 1199
    • Local 1199 PPO
  • MagnaCare
    • MagnaCare PPO
  • Medicaid
    • NY Medicaid
  • Medicare
    • Medicare
  • MetroPlus
    • MetroPlus Child Health
    • MetroPlus Essential
    • MetroPlus Exchange Plans
    • MetroPlus Family Health
    • MetroPlus Medicaid
    • MetroPlus Medicare
  • NYS Health Insurance Plan
    • The Empire Plan
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • Railroad Medicare
    • Railroad Medicare
  • Senior Whole Health
    • Senior Whole Health
  • Tricare
    • Tricare
  • UHC
    • UnitedHealthcare Community & State Plan
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
  • UPN
    • UPN Elite
  • VNS
    • Visiting Nurse Service (VNS) Medicare
  • Village Caremax
    • Village Caremax
NYU Cardiac Catheterization Associates

550 1st Avenue, 14th Floor
New York, NY 10016

Research My Research

Research Summary

Dr. Shah's research focuses on modifiable factors affecting patient outcomes in the setting of acute coronary syndrome and percutaneous coronary intervention. She has received funding from the American Heart Association, American College of Cardiology, New York State, and National Institutes of Health (KL2 Scholar) to test novel therapeutic strategies aimed at modifying abnormal metabolic and inflammatory profiles in patients with coronary and peripheral artery disease.

Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Clinical Trials and Research Studies

  • CLEAR SYNERGY (OASIS 9) - A 2x2 factorial randomized controlled trial of CoLchicine and spironolactonE in patients with ST elevation myocARdial infarction/SYNERGY Stent Registry Organization to Assess Strategies for Ischemic Syndromes 9

    Learn More
View All Research Studies (1)


Read All Publications (51)

We can help you find a doctor. Call 646-929-7800 or
browse our specialists.